Menu Close
The Conversation

Mark Butler

1

Article

1

Comment
Senior Research Fellow at the Institute for Molecular Bioscience, The University of Queensland

Mark Butler has worked in drug discovery since 1994 with a focus on natural products and has extensive experience in preclinical research, drug development, group and project management, intellectual property and workplace safety.

Current research interests include the discovery and development of new antibacterial and antifungal drug leads to clinical candidates and mode of action studies using chemical biology and metabolomic techniques.

Experience

  • 2009–present
    Senior Research Fellow Grade 2, Institute for Molecular Bioscience, The University of Queensland
  • 2002–2009
    Director Natural Product Chemistry, MerLion Pharmaceuticals Pte Ltd (Singapore)
  • 1999–2002
    Research Leader, Centre for Natural Product Research (Singapore)
  • 1994–1999
    Research Fellow, Queensland Pharmaceutical Research Institute, Griffith University
  • 1992–1994
    Postdoctoral Research Associate, Cancer Research Institute, Arizona State University (USA)

Education

  • 1993 
    The University of Melbourne, PhD
  • 1988 
    The University of Melbourne, BSc(Hons)

Research Areas

  • Natural Products Chemistry (030502)
  • Analytical Chemistry (0301)
  • Infectious Agents (060502)
  • Medical Biochemistry: Lipids (110104)
  • Medicinal And Biomolecular Chemistry (0304)